Fibroblast

A fibroblast is a connective-tissue cell that builds and maintains the structural scaffolding of organs by producing collagen and other extracellular matrix proteins. When tissue is injured, fibroblasts multiply and lay down new matrix to repair the damage. If they remain activated for too long, the repair process turns into scarring, called fibrosis.

Origin

The word combines the Latin fibra (fiber) with the Greek blastos (germ or sprout), coined in the late 19th century as microscopists identified the spindle-shaped cells that generate fibrous tissue during growth and wound healing.

Significance in Asbestos Context

Fibroblasts are the cells that physically build the scar tissue seen in asbestosis and in pleural plaques and diffuse pleural thickening. When asbestos fibers reach the lung or pleura, they trigger chronic inflammation; signaling molecules released by injured cells and macrophages (especially TGF-β) push fibroblasts into a hyperactive, collagen-producing state, and many convert into contractile myofibroblasts that stiffen and shrink the tissue. This is the biological reason patients with asbestosis develop progressive shortness of breath, reduced lung volumes, and the honeycomb scarring visible on CT scans. Understanding that the damage is fibroblast-driven also explains why current treatments (such as antifibrotic drugs like pirfenidone or nintedanib in selected cases) aim to slow fibroblast activity rather than reverse scarring that has already formed.

Example Sentence

The pulmonologist explained that the stiffening in his lungs was caused by fibroblasts laying down scar tissue around the asbestos fibers his body could not clear.

Related Terms

Asbestosis, Fibrosis, Collagen, Myofibroblast, TGF-beta, Pleural Plaques

Notes

• Ask your pulmonologist whether your imaging or biopsy reports describe "fibroblastic foci" or "active fibrosis". These findings can affect prognosis and treatment decisions.
• If you have a confirmed diagnosis of asbestosis or progressive pulmonary fibrosis, ask whether antifibrotic medications (pirfenidone, nintedanib) are appropriate for you; these drugs target the fibroblast-driven scarring process.
• Preserve copies of all pathology reports, CT scans, and pulmonary function tests; descriptions of fibrotic changes are often central evidence in asbestosis claims.
• Fibrosis caused by asbestos generally does not reverse, so early diagnosis and monitoring of lung function (FVC and DLCO) every 6–12 months is important.